Back to Trials
NCT03303716Recruiting

ASXL-Related Disorders Natural History Study

University of California, Los Angeles

Start Date

9/20/2017

Completion Date

9/1/2037

Summary

A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).

Detailed Description

Study participants will be asked to complete a series of brief surveys over time about their medical condition. The researchers will also attain primary medical records.The registry is based at UCLA as the IRB of record with collaborating sites at Boston Children's Hospital, Cincinnati Children's Hospital, and Duke University in a partnership with the Bohring-Opitz Syndrome (BOS) Foundation and ASXL-Rare Research Endowment (ARRE). The BOS Foundation and ARRE are non-profit organizations run by families of patients with ASXL-related disorders that are focused on supporting research. The data is co-managed by the researchers and the family groups. Aggregate data from the Registry will be shared with the participants as well as used for publication. The Registry is HIPPA compliant and follows all the IRB requirements regarding securing and managing patient data.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Clinical or molecular diagnosis of an ASXL related disorder Exclusion Criteria: * No clinical or molecular diagnosis of an ASXL related disorder

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Bohring-Opitz SyndromeASXL1 Gene MutationShashi-Pena SyndromeASXL2 Gene MutationBainbridge-Ropers SyndromeASXL3 Gene Mutation

Locations

University of California, Los Angeles

Los Angeles, California 90095

United States